(Q41477414)

1 October 2017

Hepatitis B virus-specific cytotoxic T lymphocyte responses in patients with acute and chronic hepatitis B virus infection (English)

1 reference

1 October 2017

1 reference

1 reference

6

Slaoui M

1 reference

1 October 2017

Van Hecke E

1

1 reference

1 October 2017

Paradijs J

2

1 reference

1 October 2017

Molitor C

3

1 reference

1 October 2017

Bastin C

4

1 reference

1 October 2017

Pala P

5

1 reference

1 October 2017

Leroux-Roels G

7

1 reference

1 October 2017

1 April 1994

1 reference

1 October 2017

Journal of Hepatology

1 reference

1 October 2017

20

1 reference

1 October 2017

4

1 reference

1 October 2017

514-523

1 reference

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

Vaccinia virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980499-4

7 January 2021

10.1016/S0168-8278(05)80499-4

Identifiers

DOI

1 reference

1 October 2017

1 reference